Novozymes Hits 2011 Financial Targets, Is Cautious on Outlook for 2012

Novozymes has reported a 13% increase in net profit to DK1.8 billion ($313 million) for full year 2010, on sales up 8% to DKr 10.5 billion. Exchange rates had a negative impact, with sales in local currencies up 10%, the company says. Acquisitions contributed 3% to the company’s growth. “I’m delighted to report that we delivered on our full-year growth expectations despite the uncertainty about the global economic situation,” says Steen Riisgaard, President & CEO. “The uncertainty is expected to continue in  2012 and...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers